ApprovalTrail

Approval · Notice of Compliance 12432 · 2011

ACUVAIL: Notice of Compliance 12432

Issued June 15, 2011

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
12432
Date
June 15, 2011
Company
Allergan IncMarkham, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Topical non-steroidal anti-inflammatory agent

Products in this notice

BrandDINStatus today
ACUVAIL02369362Marketed

Medicinal ingredients